Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiorgan Metabolic Imaging Response Assessment of Abemaciclib

NCT03339843 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT03339843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03339843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiorgan Metabolic Imaging Response Assessment of Abemaciclib
Lead sponsor
Jules Bordet Institute
Phase
Phase 2
Overall status
Completed
Start date
December 19, 2018
Completion date
December 20, 2023
Enrollment
85 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, endometrial cancer, esophageal adenocarcinoma, esophagus scc, urothelial/bladder cancer, nos